The level of buy-sell trading at Exicure is near the 324 member peer company average. The Bio Therapeutic Drugs peer group saw 274 buy/sell trades during this period for an average of 0.8 transactions per company. However, the number of shares per buy/sell trade transacted by Exicure insiders is higher. Within the peer group there were 133,272,847 shares purchased and 16,678,473 shares sold with company insiders purchasing 610,442 shares on average.
In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data sourced to create and write this story.
|Analyst Actions: B. Riley Upgrades CNO Financial Gro...|
|Sector Update: Energy Firms Trade Lower Premarket Fr...|
|Sector Update: Financial Stocks Decline Premarket Fr...|
|Tesla CEO Musk Earns About $770 Million in Milestone...|
|Sector Update: Health Care Stocks Climb Pre-Bell Friday|